Going concern
Filing comparison
EyePoint, Inc. disclosed substantial doubt about its ability to continue as a going concern
No substantial-doubt conclusion identified → Substantial doubt about ability to continue as a going concern
If the Company is unable to obtain funding, it could be forced to delay, reduce, or eliminate some or all of its research and development programs, including its clinical trials, pipeline expansion, or commercialization efforts, which could adversely affect its business prospects. Accordingly, management’s plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern. The accompanying condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and…
Evidence
- Blank check
- No
- Comparable
- Yes
- Current state
- substantial_doubt
- Current state label
- Substantial doubt about ability to continue as a going concern
- Direction
- escalated
- Located in
- going-concern note
- Prior filed
- 2026-08-05
- Prior form
- 10-Q
- Prior state
- none
- Prior state label
- No substantial-doubt conclusion identified
- Source
- ASC 205-40 going-concern note comparison
- Why
- Disclosure about the company's ability to continue as a going concern changed compared with its previous report.